Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism

NCT01956955 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT01956955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01956955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism
Lead sponsor
Ataturk University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2011
Completion date
January 31, 2014
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

this study will provide data comparing safety of lmwh versus ufh in the treatment of acute pe cases who require thrombolytic treatment.